MCI Radiation Oncology Evaluation - November 14, 2025

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Identify the most common oral complications associated with cancer therapies, including mucositis, xerostomia, and infections.	Identify the most common oral complications associated with cancer therapies, including mucositis, xerostomia, and infections. - 5	Identify the most common oral complications associated with cancer therapies, including mucositis, xerostomia, and infections. - 4	Identify the most common oral complications associated with cancer therapies, including mucositis, xerostomia, and infections. - 3	Identify the most common oral complications associated with cancer therapies, including mucositis, xerostomia, and infections. - 2	Identify the most common oral complications associated with cancer therapies, including mucositis, xerostomia, and infections. - 1
Describe the pathophysiology and clinical presentation of oral mucositis.	Describe the pathophysiology and clinical presentation of oral mucositis. - 5	Describe the pathophysiology and clinical presentation of oral mucositis. - 4	Describe the pathophysiology and clinical presentation of oral mucositis. - 3	Describe the pathophysiology and clinical presentation of oral mucositis. - 2	Describe the pathophysiology and clinical presentation of oral mucositis. - 1
Summarize current evidence-based guidelines for oral care and mucositis management in oncology patients.	Summarize current evidence-based guidelines for oral care and mucositis management in oncology patients. - 5	Summarize current evidence-based guidelines for oral care and mucositis management in oncology patients. - 4	Summarize current evidence-based guidelines for oral care and mucositis management in oncology patients. - 3	Summarize current evidence-based guidelines for oral care and mucositis management in oncology patients. - 2	Summarize current evidence-based guidelines for oral care and mucositis management in oncology patients. - 1

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence NA|Not applicable to my practice

	5	4	3	2	1
Review MRI-defined risk factors for recurrence of rectal cancer.	Review MRI-defined risk factors for recurrence of rectal cancer. - 5	Review MRI-defined risk factors for recurrence of rectal cancer. - 4	Review MRI-defined risk factors for recurrence of rectal cancer. - 3	Review MRI-defined risk factors for recurrence of rectal cancer. - 2	Review MRI-defined risk factors for recurrence of rectal cancer. - 1
Implement risk-factor based stratification to guide selection of treatment inclusive of selective RT omission, total neoadjuvant therapy and organ preservation.	Implement risk-factor based stratification to guide selection of treatment inclusive of selective RT omission, total neoadjuvant therapy and organ preservation. - 5	Implement risk-factor based stratification to guide selection of treatment inclusive of selective RT omission, total neoadjuvant therapy and organ preservation. - 4	Implement risk-factor based stratification to guide selection of treatment inclusive of selective RT omission, total neoadjuvant therapy and organ preservation. - 3	Implement risk-factor based stratification to guide selection of treatment inclusive of selective RT omission, total neoadjuvant therapy and organ preservation. - 2	Implement risk-factor based stratification to guide selection of treatment inclusive of selective RT omission, total neoadjuvant therapy and organ preservation. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so?

Please provide any additional comments or suggestions.

Name and ABS ID Required to claim MOC

You are here

MCI Radiation Oncology Evaluation - November 14, 2025